European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC

doi:10.1111/jdv.13354

Practice Guideline

. 2015 Dec;29(12):2277-94.

doi: 10.1111/jdv.13354. Epub 2015 Oct 19.

European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC

A Nast¹, P Gisondi², A D Ormerod³, P Saiag⁴, C Smith⁵, P I Spuls⁶, P Arenberger⁷, H Bachelez⁸, J Barker⁹, E Dauden¹⁰, E M de Jong¹¹, E Feist¹², A Jacobs¹, R Jobling¹³, L Kemény¹⁴, M Maccarone¹⁵, U Mrowietz¹⁶, K A Papp¹⁷, C Paul¹⁸, K Reich¹⁹, S Rosumeck¹, T Talme²⁰, H B Thio²¹, P van de Kerkhof²², R N Werner¹, N Yawalkar²³

Affiliations

¹ Division of Evidence Based Medicine, Department of Dermatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
² Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
³ Department of Dermatology, Aberdeen Royal Infirmary, Aberdeen, UK.
⁴ Service de Dermatologie, Hôpital Ambroise Paré Université Paris V, Boulogne, France.
⁵ Clinical Lead for Dermatology, St Johns Institute of Dermatology, St Thomas' Hospital, London, UK.
⁶ Department of Dermatology, Academic Medical Center, Amsterdam, The Netherlands.
⁷ Third Faculty of Medicine, Department of Dermatology, Charles University, Prague, Czech Republic.
⁸ Department of Dermatology, Hôpital Saint-Louis, Paris, France.
⁹ St. Johns Institute of Dermatology, St. Thomas' Hospital, London, UK.
¹⁰ Hospital Universitario de la Princesa, Madrid, Spain.
¹¹ University Medical Center Nijmegen St Radboud, Nijmegen, The Netherlands.
¹² Medizinische Klinik mit Schwerpunkt Rheumatologie u. klinische Immonologie, Charité - Universitätsmedizin Berlin, Berlin, Germany.
¹³ Cambridge, UK.
¹⁴ SZTE Borgyogyaszati Klinika, Szeged, Hungary.
¹⁵ Roma, Italy.
¹⁶ Department of Dermatology, Psoriasis-Center University Medical Center Schleswig Holstein, Kiel, Germany.
¹⁷ Waterloo, Canada.
¹⁸ Department of Dermatology, Paul Sabatier University, Toulouse, France.
¹⁹ Dermatologikum Hamburg, Hamburg, Germany.
²⁰ Section of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
²¹ Department of Dermatology, Erasmus University, Rotterdam, The Netherlands.
²² Department of Dermatology, University Hospital Nijmegen, Nijmegen, The Netherlands.
²³ Department of Dermatology, Inselspital, Universitätsklinik für Dermatologie, Bern, Switzerland.

PMID: 26481193
DOI: 10.1111/jdv.13354

Practice Guideline

European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC

A Nast et al. J Eur Acad Dermatol Venereol. 2015 Dec.

. 2015 Dec;29(12):2277-94.

doi: 10.1111/jdv.13354. Epub 2015 Oct 19.

Authors

Affiliations

¹ Division of Evidence Based Medicine, Department of Dermatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
² Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.
³ Department of Dermatology, Aberdeen Royal Infirmary, Aberdeen, UK.
⁴ Service de Dermatologie, Hôpital Ambroise Paré Université Paris V, Boulogne, France.
⁵ Clinical Lead for Dermatology, St Johns Institute of Dermatology, St Thomas' Hospital, London, UK.
⁶ Department of Dermatology, Academic Medical Center, Amsterdam, The Netherlands.
⁷ Third Faculty of Medicine, Department of Dermatology, Charles University, Prague, Czech Republic.
⁸ Department of Dermatology, Hôpital Saint-Louis, Paris, France.
⁹ St. Johns Institute of Dermatology, St. Thomas' Hospital, London, UK.
¹⁰ Hospital Universitario de la Princesa, Madrid, Spain.
¹¹ University Medical Center Nijmegen St Radboud, Nijmegen, The Netherlands.
¹² Medizinische Klinik mit Schwerpunkt Rheumatologie u. klinische Immonologie, Charité - Universitätsmedizin Berlin, Berlin, Germany.
¹³ Cambridge, UK.
¹⁴ SZTE Borgyogyaszati Klinika, Szeged, Hungary.
¹⁵ Roma, Italy.
¹⁶ Department of Dermatology, Psoriasis-Center University Medical Center Schleswig Holstein, Kiel, Germany.
¹⁷ Waterloo, Canada.
¹⁸ Department of Dermatology, Paul Sabatier University, Toulouse, France.
¹⁹ Dermatologikum Hamburg, Hamburg, Germany.
²⁰ Section of Dermatology and Venereology, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
²¹ Department of Dermatology, Erasmus University, Rotterdam, The Netherlands.
²² Department of Dermatology, University Hospital Nijmegen, Nijmegen, The Netherlands.
²³ Department of Dermatology, Inselspital, Universitätsklinik für Dermatologie, Bern, Switzerland.

PMID: 26481193
DOI: 10.1111/jdv.13354

No abstract available

PubMed Disclaimer

Cited by

Direct comparison of risankizumab and fumaric acid esters in systemic therapy-naïve patients with moderate-to-severe plaque psoriasis: a randomized controlled trial.
Thaçi D, Eyerich K, Pinter A, Sebastian M, Unnebrink K, Rubant S, Williams DA, Weisenseel P. Thaçi D, et al. Br J Dermatol. 2022 Jan;186(1):30-39. doi: 10.1111/bjd.20481. Epub 2021 Aug 17. Br J Dermatol. 2022. PMID: 33991341 Free PMC article. Clinical Trial.
Long-Term Treatment with Dimethyl Fumarate for Plaque Psoriasis in Routine Practice: Good Overall Effectiveness and Positive Effect on Impactful Areas.
Augustin M, Landeck L, Diemert S, Asadullah K, Hammann U, Ertner K, Hadshiew I. Augustin M, et al. Dermatol Ther (Heidelb). 2022 May;12(5):1121-1131. doi: 10.1007/s13555-022-00714-0. Epub 2022 Apr 11. Dermatol Ther (Heidelb). 2022. PMID: 35403945 Free PMC article.
The Presence of HLA-A Bw4-80I KIR Ligands Could Predict "Difficult-to-Treat" Psoriasis and Poor Response to Etanercept.
Guarene M, Pasi A, Bolcato V, Cananzi R, Piccolo A, Sbarsi I, Klersy C, Cacciatore R, Brazzelli V. Guarene M, et al. Mol Diagn Ther. 2018 Aug;22(4):471-474. doi: 10.1007/s40291-018-0345-9. Mol Diagn Ther. 2018. PMID: 29943154
Use of Secukinumab in a Cohort of Erythrodermic Psoriatic Patients: A Pilot Study.
Damiani G, Pacifico A, Russo F, Pigatto PDM, Bragazzi NL, Bonifati C, Morrone A, Watad A, Adawi M. Damiani G, et al. J Clin Med. 2019 May 31;8(6):770. doi: 10.3390/jcm8060770. J Clin Med. 2019. PMID: 31159169 Free PMC article.
Therapeutic goals and treatment response evaluation in moderate to severe psoriasis: an experts opinion document.
Belinchón Romero I, Dauden E, Ferrándiz Foraster C, González-Cantero Á, Carrascosa Carrillo JM. Belinchón Romero I, et al. Ann Med. 2021 Dec;53(1):1727-1736. doi: 10.1080/07853890.2021.1986637. Ann Med. 2021. PMID: 34601988 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC

Affiliations

European S3-Guidelines on the systemic treatment of psoriasis vulgaris--Update 2015--Short version--EDF in cooperation with EADV and IPC

Authors

Affiliations

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Similar articles

Cited by

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical